<DOC>
	<DOCNO>NCT00657761</DOCNO>
	<brief_summary>The metabolic effect T-20 completely know , since drug use combination antiretroviral agent . A short-term study healthy volunteer , double-blind crossover design vs. placebo illustrate may direct metabolic effect without influence HIV infection concurrent use drug .</brief_summary>
	<brief_title>Metabolic Effects Enfuvirtide Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Enfuvirtide</mesh_term>
	<criteria>Healthy adult male BMI 1924.9 kg/m2 No active concomitant clinical condition Negative HIV , HBV HCV serology Negative abuse drug urine test Prior psychiatric illness Prior dyslipemia Alcohol consumption &gt; 30g/day Caffeine consumption &gt; 5 units/day Current smoker Known drug allergy Participation drug trial previous 3 month No medication previous 30 day</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>